Literature DB >> 23788718

Coronary artery calcium scoring to exclude flow-limiting coronary artery disease in symptomatic stable patients at low or intermediate risk.

Mohamed Mouden1, Jorik R Timmer, Stoffer Reiffers, Ad H J Oostdijk, Siert Knollema, Jan Paul Ottervanger, Pieter L Jager.   

Abstract

PURPOSE: To assess the capability of a zero coronary artery calcium (CAC) score to help exclude flow-limiting coronary artery disease (CAD) in a homogeneous population with stable anginal complaints and a low-to-intermediate pretest likelihood.
MATERIALS AND METHODS: The study protocol had institutional ethics committee approval, with written informed consent from all patients. Between 2009 and 2011, a total of 3501 consecutive stable patients without known CAD underwent prospectively simultaneous myocardial perfusion imaging and CAC scoring on a hybrid, 64-section single photon emission computed tomography (SPECT)/computed tomography (CT) scanner. In 868 (25%) of 3501 patients, the CAC score was zero, and these patients constituted the current study population. When feasible, additional coronary CT angiography was performed in those with abnormal SPECT findings. Clinical follow-up was recorded with regard to invasive coronary angiography, coronary revascularization, nonfatal myocardial infarction, or death. Results were analyzed by using descriptive statistics.
RESULTS: In 868 patients (mean age, 54 years ± 11 [standard deviation]; 610 [70%] female, 258 [30%] male), SPECT findings were normal in 766 (88%) and abnormal in 102 (12%), with equivocal results in 41 (5%), persistent defect in 35 (4%), and ischemia in 26 (3%). In the group with abnormal SPECT findings, additional coronary CT angiography was performed in 93 patients (91%), showing nonobstructive CAD in eight patients (9%) and normal coronary arteries in 85 patients (91%). In the other nine patients (9%), invasive angiography was used to exclude obstructive CAD. At a median follow-up of 17 months (25th percentile, 11; 75th percentile, 24 months), no coronary events were recorded.
CONCLUSION: A CAC score of zero in stable patients at low or intermediate risk excludes flow-limiting CAD. These findings support the possibility of CAC scoring as a simple and safe tool to select patients for additional testing or discharge, as recommended in the literature. © RSNA, 2013.

Entities:  

Mesh:

Year:  2013        PMID: 23788718     DOI: 10.1148/radiol.13122529

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  17 in total

1.  Sequential SPECT/CT imaging for detection of coronary artery disease in a large cohort: evaluation of the need for additional imaging and radiation exposure.

Authors:  Elsemiek M Engbers; Jorik R Timmer; Jan Paul Ottervanger; Mohamed Mouden; Ad H J Oostdijk; Siert Knollema; Pieter L Jager
Journal:  J Nucl Cardiol       Date:  2015-09-22       Impact factor: 5.952

2.  Visual identification of coronary calcifications on attenuation correction CT improves diagnostic accuracy of SPECT/CT myocardial perfusion imaging.

Authors:  Nicholas D Patchett; Sumeet Pawar; Edward J Miller
Journal:  J Nucl Cardiol       Date:  2016-02-05       Impact factor: 5.952

3.  Computed tomography: The optimal imaging method for differentiation of ischemic vs non-ischemic cardiomyopathy.

Authors:  Ibrahim Danad; James K Min
Journal:  J Nucl Cardiol       Date:  2015-07-08       Impact factor: 5.952

Review 4.  Relationship between Calcium Score and Myocardial Scintigraphy in the Diagnosis of Coronary Disease.

Authors:  Fabio Paiva Rossini Siqueira; Claudio Tinoco Mesquita; Alair Augusto Sarmet M Damas Dos Santos; Marcelo Souto Nacif
Journal:  Arq Bras Cardiol       Date:  2016-07-18       Impact factor: 2.000

5.  Prognostic significance of calcified plaque among symptomatic patients with nonobstructive coronary artery disease.

Authors:  Sana Shah; Naveen Bellam; Jonathon Leipsic; Daniel S Berman; Arshed Quyyumi; Jörg Hausleiter; Stephan Achenbach; Mouaz Al-Mallah; Matthew J Budoff; Fillippo Cademartiri; Tracy Q Callister; Hyuk-Jae Chang; Benjamin J W Chow; Ricardo C Cury; Augustin J Delago; Allison L Dunning; Gudrun M Feuchtner; Martin Hadamitzky; Ronald P Karlsberg; Philipp A Kaufmann; Fay Y Lin; Kavitha M Chinnaiyan; Erica Maffei; Gilbert L Raff; Todd C Villines; Millie J Gomez; James K Min; Leslee J Shaw
Journal:  J Nucl Cardiol       Date:  2014-03-29       Impact factor: 5.952

6.  The influence of coronary calcium score on the interpretation of myocardial perfusion imaging.

Authors:  Mohamed Mouden; Jan Paul Ottervanger; Jorik R Timmer; Stoffer Reiffers; Ad H J Oostdijk; Siert Knollema; Pieter L Jager
Journal:  J Nucl Cardiol       Date:  2013-12-07       Impact factor: 5.952

7.  Coronary artery calcium score as a gatekeeper in the non-invasive evaluation of suspected coronary artery disease in symptomatic patients.

Authors:  Elsemiek M Engbers; Jorik R Timmer; Jan Paul Ottervanger
Journal:  J Nucl Cardiol       Date:  2017-02-01       Impact factor: 5.952

8.  Influence of iterative image reconstruction on CT-based calcium score measurements.

Authors:  Jochen A C van Osch; Mohamed Mouden; Jorn A van Dalen; Jorik R Timmer; Stoffer Reiffers; Siert Knollema; Marcel J W Greuter; Jan Paul Ottervanger; Piet L Jager
Journal:  Int J Cardiovasc Imaging       Date:  2014-03-28       Impact factor: 2.357

9.  Simple multimodality imaging: An easy, rapid, and inexpensive approach to improve non-invasive test accuracy.

Authors:  Todd D Miller; Martin Rodriguez-Porcel
Journal:  J Nucl Cardiol       Date:  2016-02-18       Impact factor: 5.952

Review 10.  The Synergistic Use of Coronary Artery Calcium Imaging and Noninvasive Myocardial Perfusion Imaging for Detecting Subclinical Atherosclerosis and Myocardial Ischemia.

Authors:  Alan Rozanski; Daniel S Berman
Journal:  Curr Cardiol Rep       Date:  2018-06-13       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.